This paper describes the application of exfoliated graphite nanoplatelets (xGnP) decorated with gold nanoparticles (AuNP) for the development of a label‐free electrochemical immunosensor for the determination of human cardiac troponin T (TnT), an important cardiac biomarker in the diagnosis of acute myocardial infarction (AMI). Heparin‐stabilized AuNP (AuNP‐Hep) were synthesized, characterized and supported on xGnP. The material obtained (AuNP‐Hep‐xGnP) was used as a platform to immobilize the anti‐TnT by adsorption and this was then applied in the construction of an immunosensor. Under optimized conditions, using differential pulse voltammetry (DPV) and an incubation time of 20 min, the proposed immunosensor showed linearity in the range of 0.050 to 0.35 ng mL−1 TnT, with a calculated limit of detection of 0.016 ng mL−1. The interday precision (n=7) showed a coefficient of variation of 6.5 %. Some potential interferents commonly present in blood plasma samples were investigated and the degree of interference was found to be low (less than 10 %), demonstrating adequate selectivity for analytical applications. The biosensor was successfully applied in the determination of TnT in fortified samples of human blood plasma.

No abstract

A label‐free electrochemical immunosensor based on the liquid crystal (E)‐1‐decyl‐4‐[(4‐decyloxyphenyl)diazenyl]pyridinium bromide (Br−Py), together with heparin‐stabilized gold nanoparticles (AuNP‐Hep) and Nafion is proposed for the determination of prostate‐specific antigen (PSA). The Br−Py liquid crystal presented redox properties and good film‐forming abilities on the electrode surface, and thus it is a suitable alternative as a redox probe for a label‐free electrochemical immunosensor, which could simplify the analysis methodology. The stepwise construction of the immunosensor and the incubation process (immunocomplex formation) were characterized by voltammetry and electrochemical impedance spectroscopy. The proposed immunosensor could directly detect PSA concentrations in the incubation samples, based on the suppression of the Br−Py redox peak (‘base peak’) current. After optimization, the immunosensor exhibited a linear response to PSA concentrations in the range of 0.1 to 50 ng mL−1, with a calculated detection limit of 0.08 ng mL−1. The reproducibility (coefficient of variance less than 3.0 %), selectivity and accuracy of the methodology were adequate. The immunosensor was satisfactorily applied in the quantification of PSA in human blood plasma samples.

Microcystins are potent hepatotoxins produced by cyanobacteria, which proliferate in wastewaters with high nutrient content. Due to their high toxicity and potential risk to human health, even at low concentrations, the development of a sensitive and rapid method for the monitoring of microcystin‐LR (MC‐LR) in water samples is of great importance. In this context, a new direct electrochemical nano‐immunosensor for MC‐LR detection using the liquid crystal (E)‐1‐decyl‐4‐[(4‐decyloxyphenyl)diazenyl]pyridinium bromide (Br‐Py) as a redox probe and gold nanoparticles stabilized in bovine serum albumin (AuNP‐BSA) is described herein. The microcystin‐LR antibody (anti‐MC‐LR) was covalently immobilized using N‐(3‐dimethylaminopropyl)‐N‐ethylcarbodiimide hydrochloride (EDC) and N‐hydroxysuccinimide (NHS) on an AuNP‐BSA/BrPy film. The proposed sensor response is based on the inhibition of the Br‐Py electrochemical signal after the specific interaction of MC‐LR with immobilized anti‐MC‐LR on the electrode surface. The electrochemical behavior of the immunosensor was studied by square‐wave voltammetry (SWV) and electrochemical impedance spectroscopy (EIS). Under optimized conditions, using SWV and an incubation time of 15 min, the immunosensor exhibits a linear response to MC‐LR concentrations of 0.05 to 500.0 ng mL−1 with a detection limit of 0.05 ng mL−1. The anti‐MC‐LR/AuNP‐BSA/Br‐Py/GCE was successfully applied in the determination of MC‐LR in spiked seawater samples.